Pettitt, A. R. “The Role of Alemtuzumab in Chronic Lymphocytic Leukaemia Patients With p53 Defects”. Hematology Meeting Reports (formerly Haematologica Reports), vol. 1, no. 5, June 2009, doi:10.4081/hmr.v1i5.638.